Moderna shares surge 160%, inflicting $5 billion loss on short sellers
Moderna's stock price surged 160%, resulting in a $5 billion loss for short sellers who had wagered on the company's continued decline. The dramatic rally reversed years of poor performance for the vaccine maker, catching bearish investors off guard with the stock's unexpected strength.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- BloombergTrace: Center
Moderna’s 160% Surge Burns Shorts in ‘Painful’ $5 Billion Loss
Moderna's stock price surged 160%, resulting in a $5 billion loss for short sellers who had wagered on the company's continued decline. The dramatic rally caught bearish investors off guard, reversing years of pessimism about the vaccine maker's performance. This sharp reversal demonstrates the significant financial risks involved in short selling during market reversals.
Rate outletRead original
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending